Storm Therapeutics

Series-B+
stormtherapeutics.com Biotech & Healthcare Cambridge, United Kingdom 11-50
Total Funding $102.1M
Latest Round $56M Series-B+
Last Announced Apr 16, 2026
Investors 10 Backers
Decision Makers 6 Verified

About Storm Therapeutics

Storm Therapeutics is a clinical-stage biotechnology company that discovers and develops small-molecule therapies. It focuses on RNA-modifying enzymes to treat cancer and other diseases. Its lead product, STC-15, is an inhibitor of the RNA-modifying enzyme METTL3 and is being evaluated in clinical studies for various cancers.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United Kingdom
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website stormtherapeutics.com
Domain Registered Date May 27, 2016

Social & Network Presence

X / Twitter Profile @storm_tx (974 followers) Created on Jun 2016
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $56,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $30,000,000 · Series-B+

  3. Capital Raise

    Raised $16,063,200 · Series-A

  4. Milestone

    X account created (@storm_tx)

    974 followers

  5. Milestone

    Website domain registered

    stormtherapeutics.com

Investors & Backers

10
Cambridge Innovation Capital
Fast Track Initiative, Inc.
Imperial Innovations
IP Group
M Ventures
Pfizer Venture Investments
Seroba Life Sciences
Taiho Ventures
Touchstone Innovations
UTokyo Innovation Platform

Funding History

3 Rounds
Series-B+ · Apr 16, 2026
Series-B+ · Dec 14, 2022
$30,000,000 Source
Series-A · Jun 28, 2016
$16,063,200 Source

Founders & Leadership

6

Atif Abbas

Chief Medical Officer

Work email & phone locked Unlock →

Eric Martin

Chief Development Officer

Work email & phone locked Unlock →

Eric Miska

Founder

Work email & phone locked Unlock →

Gerald McMahon

CEO and President

Work email & phone locked Unlock →

Marguerite Hutchinson

Chief Business Officer

Work email & phone locked Unlock →

Tony Kouzarides

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts